Cannabis Sativa (CBDS) 10-Q 29 Jun 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	Jun. 24, 2020
Text Block [Abstract]
Registrant Name	Cannabis Sativa, Inc.
Registrant CIK	0001360442
SEC Form	10-Q
Period End date	Mar. 31, 2020
Fiscal Year End	--12-31
Number of common stock shares outstanding		24,341,154
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Interactive Data Current	Yes
Current with reporting	Yes
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Entity File Number	000-53571
Entity Incorporation, State Country Code	NV
Entity Address, Address Line One	450 Hillside Dr. #A224
Entity Address, City or Town	Mesquite
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89024
City Area Code	702
Local Phone Number	762-3123

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current Assets
Cash	$ 345,131	$ 336,107
Accounts receivable, net	4,581	4,551
Prepaid consulting and other current assets	9,823	3,999
Advance for acquisition	0	50,000
Inventories	64,892	0
Total Current Assets	424,427	394,657
Other Assets
Investment in equity security, at fair value	67,000	48,000
Property and Equipment, Net	182,478	6,440
Intangible Assets, Net	643,900	695,218
Deposits and other assets	54,250	0
Right to use asset	21,120	0
Goodwill	1,837,202	1,837,202
Total Other Assets	2,805,950	2,586,860
Total Assets	3,230,377	2,981,517
Current Liabilities:
Accounts payable	84,558	73,579
Accrued interest - related parties	100,767	87,979
Due to Related Parties	1,084,020	1,018,520
Operating lease liability - current	6,498	0
Total Current Liabilities	1,275,843	1,180,078
Long-Term Liabilities
Operating lease liability - long-term	14,622	0
Stock payable	0	640,685
Total Long-Term Liabilities	14,622	640,685
Total Liabilities	1,290,465	1,820,763
Commitments and contingencies (Notes 6 and 8)	0	0
Stockholders' Equity:
Preferred stock $0.001 par value; 5,000,000 shares authorized; 1,254,012 and 1,021,849 issued and outstanding, respectively	1,253	1,021
Common stock $0.001 par value; 45,000,000 shares authorized; 24,341,154 and 22,224,199 shares issued and outstanding, respectively	24,342	22,226
Additional Paid-In Capital	76,173,444	74,834,032
Accumulated Deficit	(75,471,554)	(74,855,147)
Total Cannabis Sativa, Inc. Stockholders' Equity	727,485	2,132
Non-Controlling Interest	1,212,427	1,158,622
Total Stockholders' Equity	1,939,912	1,160,754
Total Liabilities and Stockholders' Equity	$ 3,230,377	$ 2,981,517

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Text Block [Abstract]
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	1,254,012	1,021,849
Preferred Stock, Shares Outstanding	1,254,012	1,021,849
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	45,000,000	45,000,000
Common Stock, Shares, Issued	24,341,154	22,224,199
Common Stock, Shares, Outstanding	24,341,154	22,224,199

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Text Block [Abstract]
Revenues	$ 493,140	$ 100,282
Cost of Revenues	187,335	45,609
Gross Profit	305,805	54,673
Operating Expenses
Professional Fees	279,086	254,088
Depreciation and amortization	51,635	140,518
Wages and salaries	184,909	32,634
Advertising	87,088	33,153
General and Administrative Expenses	375,862	332,095
Total Operating Expenses	978,580	792,488
Loss from Operations	(672,775)	(737,815)
Other (Income) and Expenses
Unrealized Gain on Investment	(19,000)	0
Interest expense - related parties	13,552	10,843
Total Other (Income) and Expense, Net	(5,448)	10,843
Loss Before Income Taxes	(667,327)	(748,658)
Income Taxes	0	0
Net Loss	(667,327)	(748,658)
Non-controlling interests net income (loss):
Loss attributable to non-controlling interest - GK Manufacturing	(54,353)	0
Loss attributable to non-controlling interest - iBudTender	(969)	(12,434)
Gain (loss) attributable to non-controlling interest - PrestoCorp	4,402	(13,465)
Total non-controlling interests net income (loss):	(50,920)	(25,899)
Net Loss Attributable To Cannabis Sativa, Inc.	$ (616,407)	$ (722,759)
Net Loss per Common Share:
Basic & Diluted	$ (0.03)	$ (0.03)
Weighted Average Common Shares Outstanding:
Basic & Diluted	23,510,224	21,392,324

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS'EQUITY (UNAUDITED) - USD ($)	Preferred Stock [Member]	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Noncontrolling Interest - Prestocorp	Noncontrolling Interest - iBudTender	Non-controlling Interest - GK Manufacturing	Total
Stockholders' Equity, Beginning Balance at Dec. 31, 2018	$ 759	$ 21,318	$ 72,971,563	$ (70,918,761)	$ 1,105,495	$ 123,454		$ 3,303,828
Shares, Outstanding, Beginning Balance at Dec. 31, 2018	759,444	21,316,201
Cancellation and retirement of shares, Value		$ (70)	70
Cancellation of performance based shares, Shares		(70,000)
Shares Issued for Services, Value		$ 35	115,965					116,000
Shares Issued for Services, Shares		35,000
Shares issued for stock payable, Value	$ 40	$ 127	454,130					454,297
Shares issued for stock payable, ,Shares	39,391	127,061
Net income (loss) for the period				(722,759)	(13,465)	(12,434)		(748,658)
Stockholders' Equity, Ending Balance at Mar. 31, 2019	$ 799	$ 21,410	73,541,728	(71,641,520)	1,092,030	111,020		3,125,467
Shares, Outstanding, Ending Balance at Mar. 31, 2019	798,835	21,408,262
Stockholders' Equity, Beginning Balance at Dec. 31, 2019	$ 1,021	$ 22,226	74,834,032	(74,855,147)	1,107,480	51,142		1,160,754
Shares, Outstanding, Beginning Balance at Dec. 31, 2019	1,021,849	22,224,199
Conversion of Preferred to Common, value	$ (80)	$ 80
Conversion of Preferred to Common, shares	(80,337)	80,337
Acquisition of GK Manufacturing assets, value		$ 100	108,900				104,725	213,725
Acquisition of GK Manufacturing assets, shares		100,000
Shares Issued for Services, Value	$ 89	$ 973	591,013					592,075
Shares Issued for Services, Shares	89,286	973,380
Shares issued for stock payable, Value	$ 223	$ 963	639,499					640,685
Shares issued for stock payable, ,Shares	223,214	963,238
Net income (loss) for the period				(616,407)	4,402	(969)	(54,353)	(667,327)
Stockholders' Equity, Ending Balance at Mar. 31, 2020	$ 1,253	$ 24,342	$ 76,173,444	$ (75,471,554)	$ 1,111,882	$ 50,173	$ 50,372	$ 1,939,912
Shares, Outstanding, Ending Balance at Mar. 31, 2020	1,254,012	24,341,154

CONDENSED CONSOLIDATED STATEME

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss for the period	$ (667,327)	$ (748,658)
Adjustments to Reconcile net loss to net cash (used in) provided by operating activities:
Bad Debts	0	1,461
Unrealized loss on investment	(19,000)	0	$ (152,000)
Depreciation and Amortization	51,635	140,518
Stock issued and to be issued for services	592,075	467,797
Changes in assets and liabilities:
Accounts Receivable	(30)	2,282
Inventories	(16,905)	5,714
Prepaid consulting and other current assets	(5,824)	(7,617)
Deposits and other assets	(53,000)	0
Accounts payable and accrued expenses	10,979	31,608
Accrued interest -related parties	12,788	0
Net Cash Used In Operating Activities:	(94,609)	(106,895)
Cash Flows from Investing Activities:
Advance to GK settled with asset acquisiton	50,000	0
Purchase of fixed assets	(11,867)	(128)
Net Cash Provided by (Used In) Investing Activities:	38,133	(128)
Cash Flows from Financing Activities:
Proceeds from related parties advances	65,500	0
Net Cash Provided by Financing Activities:	65,500	0
NET CHANGE IN CASH	9,024	(107,023)
CASH AT BEGINNING OF YEAR	336,107	151,946	151,946
CASH AT END OF YEAR	345,131	44,923	$ 336,107
Noncash investing and financing activities:
Net asset acquisition acquired with shares of common stock	213,725	0
Common Stock Issued for Stock Payable	640,685	454,296
Operating lease liability arising from acquiring right to use asset	$ 21,120	$ 0

1. Organization and Summary of

1. Organization and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Disclosure Text Block [Abstract]
1. Organization and Summary of Significant Accounting Policies	1. Organization and Summary of Significant Accounting Policies Nature of Business: Cannabis Sativa, Inc. (the “Company,” “us”, “we” or “our”) was incorporated as Ultra Sun Corp. under the laws of Nevada in November 2004. On November 13, 2013, we changed our name to Cannabis Sativa, Inc. We operate through several subsidiaries including PrestoCorp, Inc. (“PrestoCorp”), iBudtender, Inc. (“iBudtender”), Wild Earth Naturals, Inc. (“Wild Earth”), Kubby Patent and Licenses Limited Liability Company, (“KPAL”), Hi Brands, International, Inc. (“Hi Brands”), GK Manufacturing and Packaging, Inc. (“GKMP”), and Eden Holdings LLC (“Eden”). PrestoCorp and GK Manufacturing are both 51% owned subsidiaries and iBudtender is a 50.1% owned subsidiary. Wild Earth, KPAL, Hi Brands, and Eden are wholly owned subsidiaries. Currently, PrestoCorp, GKMP and iBudtender are operating subsidiaries, although iBudtender is not currently generating any revenue. The Company is reviewing opportunities for business development relating to Wild Earth, KPAL, and Hi Brands. Eden is not operating and had no activity for the three months ended March 31, 2020 and 2019. Our primary operations in the three months ended March 31, 2020 were through PrestoCorp, which provides telemedicine online referral services for customers desiring medical marijuana cards in states where medical marijuana has been legalized. GKMP commenced operations during the quarter ended March 31, 2020. The Company is also actively seeking new business opportunities for acquisition and is continually reviewing opportunities for product and brand development through our Wild Earth, Hi Brands, and KPAL subsidiaries. iBudtender is also working to complete and commercialize an application (the iBudtender App) that will provide a convenient means for sharing information about cannabis products, patients and businesses. Basis of Presentation: The fiscal year end is December 31. The accompanying condensed consolidated balance sheets as of March 31, 2020 and December 31, 2019, have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of the Company’s management all material adjustments (consisting only of normal recurring adjustments) which are considered necessary for a fair presentation of the interim financial statements have been included. Operating results for the three months ended March 31, 2020 are not necessarily indicative of the results of operations expected for the year ending December 31, 2020. The interim financial statements should be read in conjunction with the audited financial statements and related footnotes set forth in our annual report filed on Form 10-K for the year ended December 31, 2019 as filed with the United States Securities and Exchange Commission on May 14, 2020. Principles of Consolidation: The condensed consolidated financial statements include the accounts of Cannabis Sativa, Inc., and its wholly-owned subsidiaries; Wild Earth Naturals, Inc., Hi-Brands International, Inc., Eden Holdings LLC, our 50.1% ownership of iBudtender Inc., our 51% ownership of PrestoCorp, and our 51% ownership of GK Manufacturing Inc., (collectively referred to as the “Company”). All significant inter-company balances have been eliminated in consolidation. We hold controlling interests in iBudTender, PrestoCorp and GK Manufacturing and exercise control through management practices and oversight by the Company’s Board of Directors. GK Manufacturing was established in February 2020. Non-controlling Interests: Non-controlling interests are portions of entities included in the condensed consolidated financial statements that are not attributable to the Company. Non-controlling interest are identified separately from the Company’s stockholders’ equity and its net income (loss). Non-controlling interest equity balances include the non-controlling entity’s initial contribution at the date of the original acquisition, ongoing contributions, distributions, and percentage share of earnings since inception. The non-controlling interests are calculated based on percentages of ownership. Going Concern: The Company has an accumulated deficit of $75,471,554 at March 31, 2020, which, among other factors, raises substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to generate profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they are due. Use of Estimates: The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant estimates and assumptions by management affect the allowance for doubtful accounts, the carrying value of long-lived assets (including goodwill and intangible assets), the provision for income taxes and related deferred tax accounts, certain accrued liabilities, revenue recognition, contingencies, and the value attributed to stock-based awards. Accounts Receivable: We estimate credit loss reserves for accounts receivable on an individual receivable basis. A specific allowance reserve is established based on expected future cash flows and the financial condition of the debtor. We charge off customer balances in part or in full when it is more likely than not that we will not collect that amount of the balance due. We consider any balance unpaid after the contract payment period to be past due. Inventories: Inventory costs, when applicable, include those costs directly attributable to the manufacture of the product before sale. Inventory consists of raw materials and finished goods and is carried at the lower of cost or net realizable value, using the first-in, first-out method of determining cost. As of March 31, 2020, the Company had $64,892 in inventory relating to GKMP. Inventory consists of the raw materials and packaging used to manufacture CBD infused products for our customers. As of December 31, 2019, the Company had no inventory. Property and Equipment: Property and equipment are recorded at cost. Depreciation is provided for on the straight-line method over the estimated useful lives of the assets. The average lives range from five (5) to ten (10) years. Leasehold improvements are amortized on the straight-line method over the lesser of the lease term or the useful life. Maintenance and repairs that neither materially add to the value of the property nor appreciably prolong its life are charged to expense as incurred. Betterments or renewals are capitalized when incurred. Fair Value of Financial Instruments: The carrying amounts of cash and cash equivalents and amounts due to related parties approximate fair value given their short-term nature. Cash: Cash is held at major financial institutions and insured by the Federal Deposit Insurance Corporation (FDIC) up to federal insurance limits. The Company considers all highly liquid investments purchased with an original maturity of three months or less when acquired to be cash equivalents. Net Loss per Share: Net loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding for the period and contains no dilutive securities. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of the Company. Potentially dilutive shares are excluded from the calculation of diluted net loss per share because the effect is anti-dilutive. At March 31, 2020 and March 31, 2019 the Company had 125,000 and 49,900 outstanding warrants, respectively, that would be dilutive to future periods net income. Also, at March 31, 2020 and March 31, 2019 the Company had 1,254,012 and 798,835 shares of convertible Series A preferred stock, respectively, that would be dilutive to future periods net income. See Note 6. Revenue Recognition: Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company recognizes revenue from the sale of products and services in accordance with ASC 606,” Revenue Recognition • identify the contract with a customer; • identify the performance obligations in the contract; • determine the transaction price; • allocate the transaction price to performance obligations in the contract; and • recognize revenue as the performance obligation is satisfied. Provision for sales incentives, discounts and returns and allowances, if applicable, are accounted for as reductions of revenue in the period the related sales are recorded. The Company had no warranty costs associated with the sales of its products in the periods presented in the accompanying Consolidated Statements of Operations and no provision for warranty expenses has been included. The Company generates revenue based on a per telehealth visit basis for clients looking to obtain a permit to use marijuana for medical purposes in states that have legalized medical marijuana. Revenues are recognized when the Company satisfies its performance obligation to stand ready to provide telehealth services. This occurs at the same time an online client subscribes for the visit and gains access to our network of health care professionals. The billing and payment processes are automated through our online platform. Revenue is recognized in an amount that reflects the consideration that is received in exchange for the service. With the recent addition of GKMP, the Company will also be reporting revenue from manufacturing operations in future periods. The Company will recognize revenue from manufacturing operations when manufacturing and packaging processes are complete, and the products are shipped to the customer. In the quarter ended March 31, 2020, the Company operated as one reportable segment. Investments Investments in equity securities that are less than 20% owned are stated at fair value. The Company recognizes unrealized holding gains and losses in other (Income) Expenses in the condensed consolidated statement of operations. On disposal of an investment, the difference between the disposal proceeds and the carrying amount is recognized as income or loss on the condensed consolidated statement of operations. Intangible Assets and Goodwill: We account for intangible assets and goodwill in accordance with ASC 350 “Intangibles-Goodwill and Other” Intangible asset amounts represent the acquisition date fair values of identifiable intangible assets acquired. The fair values of the intangible assets were determined by using the income approach, discounting projected future cash flows based on management’s expectations of the current and future operating environment. The rates used to discount projected future cash flows reflected a weighted average cost of capital based on our industry, capital structure and risk premiums including those reflected in the current market capitalization. Definite-lived intangible assets are amortized over their useful lives, which have historically ranged from 5 to 10 years. The carrying amounts of our definite-lived intangible assets are evaluated for recoverability whenever events or changes in circumstances indicate that the entity may be unable to recover the asset’s carrying amount. We do not have any indefinite-lived intangible assets recorded from acquisitions. Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill is not amortized but is tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset may be impaired. The fair value of the reporting unit is evaluated on qualitative factors to determine if the reported value may be impaired. If the qualitative factors indicate a likelihood of impairment, we then evaluate carrying value of the reporting unit based on quantitative factors using the income approach. An impairment charge is recognized for the excess of the carrying value of goodwill for the reporting unit over its implied fair value. ​​ Advertising Expense: Advertising costs are expensed as incurred and are included in general and administrative expense in the accompanying consolidated statements of operations. Advertising costs were $87,088 and $33,153 for the three months ended March 31, 2020 and 2019, respectively. Stock-Based Compensation: Stock-based payments to employees and non-employees are recognized at their fair values. Compensation expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). The Company uses the Black-Scholes option pricing model when necessary as the most appropriate fair value method for option awards. Most awards have been in the form of shares of the Company’s common and preferred stock issued under the Company’s 2017 Stock Plan. See Note 6. The Company currently recognizes compensation costs immediately as our awards are 100% vested at the time of issuance. Income Taxes: The Company utilizes the liability method of accounting for income taxes which requires that deferred tax assets and liabilities be recorded to reflect the future tax consequences of temporary differences between the book and tax basis of various assets and liabilities. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Additionally, deferred tax assets are evaluated, and a valuation allowance is established if it is more likely than not that all or a portion of the deferred tax asset will not be realized. There can be no assurance that the Company’s future operations will produce sufficient earnings so that the deferred tax asset can be fully utilized. The Company currently maintains a full valuation allowance against net deferred tax assets. Leases: The Company determines if an arrangement is a lease, or contains a lease, at the inception of an arrangement. If the Company determines that the arrangement is a lease, or contains a lease, at lease inception, it then determines whether the lease is an operating lease or finance lease. Operating and finance leases result in recording a right-of-use (“ROU”) asset and lease liability on the consolidated balance sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. For purposes of calculating operating lease ROU assets and operating lease liabilities, the Company uses the non-cancellable lease term plus options to extend that it is reasonably certain to exercise. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. The Company’s leases generally do not provide an implicit rate. As such, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company has elected not to recognize ROU assets and lease liabilities that arise from short-term (12 months or less) leases for any class of underlying asset. The Company has elected not to separate lease and non-lease components for any class of underlying asset. Recent Accounting Pronouncements: Accounting Standards Updates Adopted In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The update simplifies how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Step 2 measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount. This update is effective for annual and interim periods beginning after December 15, 2019, and interim periods within that reporting period. The adoption of the new guidance on January 1, 2020 did not have a material impact on the Company’s consolidated financial statements. In August 2018, the FASB issued ASU No. 2018-13 Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement. The update removes, modifies, and makes additions to the disclosure requirements on fair value measurements. The update was adopted as of January 1, 2020, and its adoption did not have a material impact on the Company’s financial statements. Accounting Standards Updates to Become Effective in Future Periods In December 2019, the FASB issued ASU No. 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The update contains a number of provisions intended to simplify the accounting for income taxes. The update is effective for fiscal years beginning after December 15, 2020, with early adoption permitted. Management is evaluating the impact of this update on the Company’s financial statements. Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. Fair Value Measurements When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. We measure our investment in equity securities at fair value on a recurring basis. The Company’s equity securities are valued using inputs observable in active markets and are therefore classified as Level 1 within the fair value hierarchy.

2. Property and Equipment

2. Property and Equipment	3 Months Ended
	Mar. 31, 2020
Disclosure Text Block [Abstract]
2. Property and Equipment	2. Property and Equipment Property and equipment consisted of the following at March 31, 2020 and December 31, 2019: March 31, 2020 December 31, 2019 Furniture and Equipment $ 193,769 $ 17,414 Leasehold Improvements 2,500 2,500 196,269 19,914 Less: Accumulated Depreciation (13,791) (13,474) Net Property and Equipment $ 182,478 $ 6,440 Depreciation expense for the three months ended March 31, 2020 and 2019 was $317 and $779, respectively.

3. Intangibles and Goodwill

3. Intangibles and Goodwill	3 Months Ended
	Mar. 31, 2020
Disclosure Text Block [Abstract]
3. Intangibles and Goodwill	3. Intangibles and Goodwill The Company considers all intangibles to be definite-lived assets with lives of 5 to 10 years. Intangibles consisted of the following at March 31, 2020 and December 31, 2019: March 31, 2020 December 31, 2019 CBDS.com website (Cannabis Sativa) $ 13,999 $ 13,999 Intellectual Property Rights (PrestoCorp) 240,000 240,000 Patents and Trademarks (KPAL) 1,281,411 1,281,411 Total Intangibles 1,535,410 1,535,410 Less: Accumulated Amortization (891,510) (840,192) Net Intangible Assets $ 643,900 $ 695,218 Amortization expense for the three months ended March 31, 2020 and 2019 was $51,318 and $139,739, respectively. Amortization of intangibles for each of the next five years is: 2021 $ 196,239 2022 $ 167,323 2023 $ 159,321 2024 $ 121,017 Goodwill in the amount of $3,010,202 was recorded as part of the acquisition of PrestoCorp that occurred on August 1, 2017. Cumulative impairment of the PrestoCorp goodwill totals $1,173,000 as of March 31, 2020 and December 31, 2019. Goodwill in the amount of $336,667 was recorded as part of the acquisition of iBudtender that occurred on August 8, 2016. For the year ended December 31, 2019 the Company recorded a $336,667 impairment of the iBudtender goodwill. The impairment of the iBudtender goodwill was due to delays in completion of the iBudTender software and mobile app, and failure to commence viable business operations, as well as the uncertainty surrounding the future of the business opportunity. Cumulative impairment of the iBudTender goodwill totals $336,667 as of March 31, 2020 and December 31, 2019. There were no additions, deletions, and impairments recognized in the three months ended March 31, 2020 and 2019.

4. Related Party Transactions

4. Related Party Transactions	3 Months Ended
	Mar. 31, 2020
Disclosure Text Block [Abstract]
4. Related Party Transactions	4. Related Party Transactions The Company has received advances from related parties and officers of the Company to cover operating expenses. Related parties include the officers and directors of the Company, and a significant shareholder holding in excess of a 10% interest in the Company. As of March 31, 2020, and December 31, 2019, amounts due to the related parties were $1,084,020 and $1,018,520, respectively. During the three months ended March 31, 2020 and 2019, the Company recorded interest expense related to these advances at the rates between 5% and 8% per annum and in the amount of $13,552 and $10,843, respectively. The Company does not have written notes payable for these balances but has a verbal understanding with the related parties that written notes will be created in 2020 to reflect the balances due and payable December 31, 2025. At March 31, 2020 and December 31, 2019, there was $100,767 and $87,979, respectively, of accrued interest on these advances. At March 31, 2020 and December 31, 2019, the Company had a note payable to the founder of iBudtender of $10,142 and $10,142, respectively, which is included in due to related parties on the consolidated balance sheets. The note earns interest at 0% and was due on December 2019. The note has not yet been paid pending further review of the iBudtender business and adjustment of the agreements between the parties. During the three months ended March 31, 2020 and 2019, the Company incurred approximately $45,000 and $17,000, respectively, for consulting services from a nephew of the Company’s president. These services were paid in shares of the Company’s common stock. During the three months ended March 31, 2020 and 2019, the Company paid officer and director compensation for services in shares of common stock in order to reduce operating cash flow requirements. The shares were recorded at fair value at the time of issuance as compensation expense. See Note 6 regarding shares issued to related parties. These amounts totaled $196,674 and $0 at March 31, 2020 and March 31, 2019, respectively. The amounts are included in the statements of operations in general and administrative expenses.

5. Investments

5. Investments	3 Months Ended
	Mar. 31, 2020
Investments, All Other Investments [Abstract]
5. Investments	5. Investments. In 2018, the Company purchased 10,000,000 shares of common stock of Medical Cannabis Payment Solutions (ticker: REFG) in exchange for 1,000,000 units of Weed coins (valued at $200,000). At March 31, 2020, the fair value of the investment in REFG was adjusted to $67,000 based on the closing price of the stock on that date, which resulted in an unrealized gain on investment of $19,000 during the three month period ended March 31, 2020. At December 31, 2019, the fair value of the investment in REFG was adjusted to $48,000 based on the closing price of the stock on that date, which resulted in an unrealized loss on investment of $152,000 during the year ended December 31, 2019.

6. Stockholders' Equity

6. Stockholders' Equity	3 Months Ended
	Mar. 31, 2020
Disclosure Text Block [Abstract]
6. Stockholders' Equity	6. Stockholders’ Equity Share Capital The authorized capital of the Company consists of 45,000,000 shares of Common Stock with a par value of $0.001 and 5,000,000 shares of preferred stock issuable in series with such rights, preferences and conditions as the Board of Directors may establish. The Company has designated and established the rights of Series A preferred stock (“Series A”) with a par value of $0.001. The Company is authorized to issue up to 5,000,000 shares of Series A. The holders of Series A are entitled to dividends if the Company declares a dividend on common shares, have no liquidation preference, have voting rights equal to 1 vote per share, and can be converted into one share of common at any time. In the three months ended March 31, 2020, a related party converted 80,337 preferred shares into 80,337 shares of common stock. No preferred shares were converted in the three months ended March 31, 2019. Shares of Stock issued for Asset Acquisition In the three months ended March 31, 2020, the Company acquired assets and established GK Manufacturing and Packaging, Inc. (“GKMP”) to conduct contract manufacturing operations for customers seeking to obtain CBD infused products, including salves, tinctures, edibles, and other products containing CBD. In connection with the acquisition, the Company issued two key individuals an aggregate of 100,000 shares of common stock with a fair value of $109,000 for a 51% interest in GKMP. Assets acquired included inventory needed for manufacturing the CBD products, a packaging line, and other manufacturing equipment. The assets were valued at $213,725, of which $104,725 relates to the 49% non-controlling interest. GKMP also assumed the payments on a lease for equipment, agreed to provide up to $500,000 of additional working capital to GKMP, and agreed to an earnout provision where additional shares of common stock may become issuable to the key individuals in the event certain performance standards are met. See Note 7. Upon completion of the acquisition of assets for GKMP, GKMP entered into employment agreements with the two key individuals. The employment agreements are terminable at any time with or without cause, but in the event of termination without cause, the salary will continue for six months. Salary for the president of GKMP is set at $65,000 per annum and salary for the Vice President – Sales and Marketing is set at $50,000 per annum. The agreements also provide the individuals with expense reimbursements and other employee benefits comparable to those being offered to the other employees of the Company. Currently, GKMP has not established any other employee benefit programs. The 49% non-controlling interest is considered a related party to the Company because the non-controlling interest is owned, in part by the president of GKMP. The completion of the GKMP asset acquisition resulted in payment of a finder’s fee to an unrelated party. The finder’s fee was paid by issuance of 50,000 shares of common stock with a fair value at the time of issuance of $36,000. 2017 Stock Plan On July 28, 2017, the Company adopted the Cannabis Sativa 2017 Stock Plan which authorized the Company to utilize common stock to compensate employees, officers, directors, and independent contractors for services provided to the Company. The Company authorized up to 3,000,000 shares of common stock to be issued pursuant to the 2017 Stock Plan. At March 31, 2020, the Company was authorized to issue up to 954,720 additional shares under the 2017 Stock Plan. Warrants At March 31, 2020 and December 31, 2019, the Company had outstanding warrants to purchase 125,000 shares and 174,900 shares of the Company’s common stock, respectively. The exercise price on 125,000 warrants was $0.80 per share and these warrants expire in November 2022. The exercise price on 49,900 warrants was $2.00 per share and these warrants expired February 1, 2020. Securities Issuances for Acquisitions and Services During the quarter ended March 31, 2020, shares of common stock and preferred stock were issued to related and non-related parties for services. The following table breaks out the issuances by type of transaction and by related and non-related parties under the plan. Three months ended March 31, 2020 Acquistions Services Total Related Parties Common Value Common Preferred Value Common Preferred Value David Tobias, Officer, Director - $ - - 89,286 $ 42,857 - 89,286 $ 42,857 Brad Herr, Officer, Director - - 131,964 - 63,342 131,964 - 63,342 Robert Tankson, Director - - 84,326 - 40,476 84,326 - 40,476 Cathy Carroll, Director - - 89,286 - 42,857 89,286 - 42,857 Trevor Reed, Director - - 14,881 - 7,142 14,881 - 7,142 Total for related parties - $ - 320,457 89,286 $ 196,674 320,457 89,286 $ 196,674 Related parties - acquistion 100,000 $ 109,000 652,923 - $ 395,401 752,923 - $ 504,401 Aggregate Totals 100,000 $ 109,000 973,380 89,286 $ 592,075 1,073,380 89,286 $ 701,075 During the three months ended March 31, 2020, David Tobias, Chief Executive Officer and Director, converted 80,337 shares of preferred stock into common stock in accordance with the terms of the preferred stock. No preferred shares were converted in the three months ended March 31, 2019 During the quarter ended March 31, 2019, shares of common stock were issued to non-related parties. The following table breaks out the issuances by type of transaction and by related and non-related parties under the plan. Three months ended March 31, 2019 Services Common Preferred Value Unrelated parties issued 35,000 - $ 116,000 Unrelated Parties Cancelled (70,000) - - Aggregate Totals (35,000) - $ 116,000 Stock Payable At December 31, 2019, there was a balance of $640,685 in stock payable. The balance in stock payable at December 31, 2019 was paid through issuance of 223,214 preferred shares and 963,238 common shares of stock in the quarter ended March 31, 2020. Of these shares issued, 223,214 shares of preferred stock and 521,411 shares of common stock valued in the aggregate at $196,674 were issued to officers and directors of the Company. The balance in stock payable at March 31, 2020 was $0. At December 31, 2018, there was a balance of $532,146 in stock payable. The balance in stock payable at December 31, 2018 was paid through issuance of 39,391 preferred shares and 127,061 common shares of stock in the quarter ended March 31, 2019. Of these shares issued, 39,391 shares of preferred stock and 85,681 shares of common stock, valued in the aggregate at $340,198 were issued to officers and directors of the Company.

7. Commitments and Contingencie

7. Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Disclosure Text Block [Abstract]
7. Commitments and Contingencies	7. Commitments and Contingencies Leases. PrestoCorp leases office space through WeWork in New York for $2,444 per month on a month to month arrangement. Until February 2019, PrestoCorp also leased space in San Francisco for $2,800 per month. PrestoCorp terminated its lease and closed its office in San Francisco as of the end of February 2019. Primary operations for PrestoCorp are now based in New York City. Rent expense for PrestoCorp for the three months ended March 31, 2020 and 2019 was $7,322 and $8,044, respectively. GKMP leases a commercial printer used in its manufacturing and packaging operations. The Company assumed the lease as part of the acquisition of GKMP’s assets (see Note 6). On the date it was assumed, the Company recognized an operating lease liability and a right of use asset of $23,286. To calculate the liability and right of use asset, the Company utilized a 10% incremental borrowing rate to discount the future rent payments of $683 per month over the remaining lease term of 40 months. For the quarter ended March 31, 2020, the Company recognized $683 in rent expense in the consolidated statements of operations. At March 31, 2020, the remaining lease term is 39 months. The lessor holds a deposit of $1,250 on the lease. Future minimum lease payments over the remaining term are as follows: Nine months ended December 31, 2020 $ 6,143 Twelve months ended December 31, 2021 8,190 Twelve months ended December 31, 2022 8,190 Six months ended June 30, 2023 4,095 Total 26,618 Less imputed interest (5,498) Net lease liability 21,120 Current portion (6,498) Long term $ 14,622 Litigation. Shares in Escrow. Contingent Consideration. Working Capital Obligation.

8. COVID 19

8. COVID 19	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
8. COVID 19	8. COVID- 19: The outbreak of COVID-19, the coronavirus, has grown both in the United States and globally, and related government and private sector responsive actions have adversely affected the Company’s business operations. The World Health Organization has declared Covid-19 to be a global pandemic, resulting in an economic downturn and changes in global economic policy that will reduce demand for the Company’s products and may have an adverse impact on the Company’s business, operating results and financial condition.

1. Organization and Summary o_2

1. Organization and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Policy Text Block [Abstract]
Nature of Business	Nature of Business: Cannabis Sativa, Inc. (the “Company,” “us”, “we” or “our”) was incorporated as Ultra Sun Corp. under the laws of Nevada in November 2004. On November 13, 2013, we changed our name to Cannabis Sativa, Inc. We operate through several subsidiaries including PrestoCorp, Inc. (“PrestoCorp”), iBudtender, Inc. (“iBudtender”), Wild Earth Naturals, Inc. (“Wild Earth”), Kubby Patent and Licenses Limited Liability Company, (“KPAL”), Hi Brands, International, Inc. (“Hi Brands”), GK Manufacturing and Packaging, Inc. (“GKMP”), and Eden Holdings LLC (“Eden”). PrestoCorp and GK Manufacturing are both 51% owned subsidiaries and iBudtender is a 50.1% owned subsidiary. Wild Earth, KPAL, Hi Brands, and Eden are wholly owned subsidiaries. Currently, PrestoCorp, GKMP and iBudtender are operating subsidiaries, although iBudtender is not currently generating any revenue. The Company is reviewing opportunities for business development relating to Wild Earth, KPAL, and Hi Brands. Eden is not operating and had no activity for the three months ended March 31, 2020 and 2019. Our primary operations in the three months ended March 31, 2020 were through PrestoCorp, which provides telemedicine online referral services for customers desiring medical marijuana cards in states where medical marijuana has been legalized. GKMP commenced operations during the quarter ended March 31, 2020. The Company is also actively seeking new business opportunities for acquisition and is continually reviewing opportunities for product and brand development through our Wild Earth, Hi Brands, and KPAL subsidiaries. iBudtender is also working to complete and commercialize an application (the iBudtender App) that will provide a convenient means for sharing information about cannabis products, patients and businesses.
Basis of Presentation	Basis of Presentation: The fiscal year end is December 31. The accompanying condensed consolidated balance sheets as of March 31, 2020 and December 31, 2019, have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of the Company’s management all material adjustments (consisting only of normal recurring adjustments) which are considered necessary for a fair presentation of the interim financial statements have been included. Operating results for the three months ended March 31, 2020 are not necessarily indicative of the results of operations expected for the year ending December 31, 2020. The interim financial statements should be read in conjunction with the audited financial statements and related footnotes set forth in our annual report filed on Form 10-K for the year ended December 31, 2019 as filed with the United States Securities and Exchange Commission on May 14, 2020.
Principles of Consolidation	Principles of Consolidation: The condensed consolidated financial statements include the accounts of Cannabis Sativa, Inc., and its wholly-owned subsidiaries; Wild Earth Naturals, Inc., Hi-Brands International, Inc., Eden Holdings LLC, our 50.1% ownership of iBudtender Inc., our 51% ownership of PrestoCorp, and our 51% ownership of GK Manufacturing Inc., (collectively referred to as the “Company”). All significant inter-company balances have been eliminated in consolidation. We hold controlling interests in iBudTender, PrestoCorp and GK Manufacturing and exercise control through management practices and oversight by the Company’s Board of Directors. GK Manufacturing was established in February 2020.
Non-controlling Interests	Non-controlling Interests: Non-controlling interests are portions of entities included in the condensed consolidated financial statements that are not attributable to the Company. Non-controlling interest are identified separately from the Company’s stockholders’ equity and its net income (loss). Non-controlling interest equity balances include the non-controlling entity’s initial contribution at the date of the original acquisition, ongoing contributions, distributions, and percentage share of earnings since inception. The non-controlling interests are calculated based on percentages of ownership.
Going Concern	Going Concern: The Company has an accumulated deficit of $75,471,554 at March 31, 2020, which, among other factors, raises substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to generate profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they are due.
Use of Estimates	Use of Estimates: The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant estimates and assumptions by management affect the allowance for doubtful accounts, the carrying value of long-lived assets (including goodwill and intangible assets), the provision for income taxes and related deferred tax accounts, certain accrued liabilities, revenue recognition, contingencies, and the value attributed to stock-based awards.
Accounts Receivable	Accounts Receivable: We estimate credit loss reserves for accounts receivable on an individual receivable basis. A specific allowance reserve is established based on expected future cash flows and the financial condition of the debtor. We charge off customer balances in part or in full when it is more likely than not that we will not collect that amount of the balance due. We consider any balance unpaid after the contract payment period to be past due.
Inventories	Inventories: Inventory costs, when applicable, include those costs directly attributable to the manufacture of the product before sale. Inventory consists of raw materials and finished goods and is carried at the lower of cost or net realizable value, using the first-in, first-out method of determining cost. As of March 31, 2020, the Company had $64,892 in inventory relating to GKMP. Inventory consists of the raw materials and packaging used to manufacture CBD infused products for our customers. As of December 31, 2019, the Company had no inventory.
Property and Equipment	Property and Equipment: Property and equipment are recorded at cost. Depreciation is provided for on the straight-line method over the estimated useful lives of the assets. The average lives range from five (5) to ten (10) years. Leasehold improvements are amortized on the straight-line method over the lesser of the lease term or the useful life. Maintenance and repairs that neither materially add to the value of the property nor appreciably prolong its life are charged to expense as incurred. Betterments or renewals are capitalized when incurred.
Fair Value of Financial Instruments	Fair Value of Financial Instruments: The carrying amounts of cash and cash equivalents and amounts due to related parties approximate fair value given their short-term nature.
Cash	Cash: Cash is held at major financial institutions and insured by the Federal Deposit Insurance Corporation (FDIC) up to federal insurance limits. The Company considers all highly liquid investments purchased with an original maturity of three months or less when acquired to be cash equivalents.
Net Loss per Share	Net Loss per Share: Net loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding for the period and contains no dilutive securities. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of the Company. Potentially dilutive shares are excluded from the calculation of diluted net loss per share because the effect is anti-dilutive. At March 31, 2020 and March 31, 2019 the Company had 125,000 and 49,900 outstanding warrants, respectively, that would be dilutive to future periods net income. Also, at March 31, 2020 and March 31, 2019 the Company had 1,254,012 and 798,835 shares of convertible Series A preferred stock, respectively, that would be dilutive to future periods net income. See Note 6.
Revenue Recognition	Revenue Recognition: Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company recognizes revenue from the sale of products and services in accordance with ASC 606,” Revenue Recognition • identify the contract with a customer; • identify the performance obligations in the contract; • determine the transaction price; • allocate the transaction price to performance obligations in the contract; and • recognize revenue as the performance obligation is satisfied. Provision for sales incentives, discounts and returns and allowances, if applicable, are accounted for as reductions of revenue in the period the related sales are recorded. The Company had no warranty costs associated with the sales of its products in the periods presented in the accompanying Consolidated Statements of Operations and no provision for warranty expenses has been included. The Company generates revenue based on a per telehealth visit basis for clients looking to obtain a permit to use marijuana for medical purposes in states that have legalized medical marijuana. Revenues are recognized when the Company satisfies its performance obligation to stand ready to provide telehealth services. This occurs at the same time an online client subscribes for the visit and gains access to our network of health care professionals. The billing and payment processes are automated through our online platform. Revenue is recognized in an amount that reflects the consideration that is received in exchange for the service. With the recent addition of GKMP, the Company will also be reporting revenue from manufacturing operations in future periods. The Company will recognize revenue from manufacturing operations when manufacturing and packaging processes are complete, and the products are shipped to the customer. In the quarter ended March 31, 2020, the Company operated as one reportable segment.
Investments	Investments Investments in equity securities that are less than 20% owned are stated at fair value. The Company recognizes unrealized holding gains and losses in other (Income) Expenses in the condensed consolidated statement of operations. On disposal of an investment, the difference between the disposal proceeds and the carrying amount is recognized as income or loss on the condensed consolidated statement of operations.
Intangible Assets and Goodwill	Intangible Assets and Goodwill: We account for intangible assets and goodwill in accordance with ASC 350 “Intangibles-Goodwill and Other” Intangible asset amounts represent the acquisition date fair values of identifiable intangible assets acquired. The fair values of the intangible assets were determined by using the income approach, discounting projected future cash flows based on management’s expectations of the current and future operating environment. The rates used to discount projected future cash flows reflected a weighted average cost of capital based on our industry, capital structure and risk premiums including those reflected in the current market capitalization. Definite-lived intangible assets are amortized over their useful lives, which have historically ranged from 5 to 10 years. The carrying amounts of our definite-lived intangible assets are evaluated for recoverability whenever events or changes in circumstances indicate that the entity may be unable to recover the asset’s carrying amount. We do not have any indefinite-lived intangible assets recorded from acquisitions. Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill is not amortized but is tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset may be impaired. The fair value of the reporting unit is evaluated on qualitative factors to determine if the reported value may be impaired. If the qualitative factors indicate a likelihood of impairment, we then evaluate carrying value of the reporting unit based on quantitative factors using the income approach. An impairment charge is recognized for the excess of the carrying value of goodwill for the reporting unit over its implied fair value.
Advertising Expense	Advertising Expense: Advertising costs are expensed as incurred and are included in general and administrative expense in the accompanying consolidated statements of operations. Advertising costs were $87,088 and $33,153 for the three months ended March 31, 2020 and 2019, respectively.
Stock-Based Compensation	Stock-Based Compensation: Stock-based payments to employees and non-employees are recognized at their fair values. Compensation expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). The Company uses the Black-Scholes option pricing model when necessary as the most appropriate fair value method for option awards. Most awards have been in the form of shares of the Company’s common and preferred stock issued under the Company’s 2017 Stock Plan. See Note 6. The Company currently recognizes compensation costs immediately as our awards are 100% vested at the time of issuance.
Income Taxes	Income Taxes: The Company utilizes the liability method of accounting for income taxes which requires that deferred tax assets and liabilities be recorded to reflect the future tax consequences of temporary differences between the book and tax basis of various assets and liabilities. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Additionally, deferred tax assets are evaluated, and a valuation allowance is established if it is more likely than not that all or a portion of the deferred tax asset will not be realized. There can be no assurance that the Company’s future operations will produce sufficient earnings so that the deferred tax asset can be fully utilized. The Company currently maintains a full valuation allowance against net deferred tax assets.
Leases	Leases: The Company determines if an arrangement is a lease, or contains a lease, at the inception of an arrangement. If the Company determines that the arrangement is a lease, or contains a lease, at lease inception, it then determines whether the lease is an operating lease or finance lease. Operating and finance leases result in recording a right-of-use (“ROU”) asset and lease liability on the consolidated balance sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. For purposes of calculating operating lease ROU assets and operating lease liabilities, the Company uses the non-cancellable lease term plus options to extend that it is reasonably certain to exercise. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. The Company’s leases generally do not provide an implicit rate. As such, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company has elected not to recognize ROU assets and lease liabilities that arise from short-term (12 months or less) leases for any class of underlying asset. The Company has elected not to separate lease and non-lease components for any class of underlying asset.
Recent Accounting Pronouncements	Recent Accounting Pronouncements: Accounting Standards Updates Adopted In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The update simplifies how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Step 2 measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount. This update is effective for annual and interim periods beginning after December 15, 2019, and interim periods within that reporting period. The adoption of the new guidance on January 1, 2020 did not have a material impact on the Company’s consolidated financial statements. In August 2018, the FASB issued ASU No. 2018-13 Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement. The update removes, modifies, and makes additions to the disclosure requirements on fair value measurements. The update was adopted as of January 1, 2020, and its adoption did not have a material impact on the Company’s financial statements. Accounting Standards Updates to Become Effective in Future Periods In December 2019, the FASB issued ASU No. 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The update contains a number of provisions intended to simplify the accounting for income taxes. The update is effective for fiscal years beginning after December 15, 2020, with early adoption permitted. Management is evaluating the impact of this update on the Company’s financial statements. Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption.
Fair Value Measurements	Fair Value Measurements When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. We measure our investment in equity securities at fair value on a recurring basis. The Company’s equity securities are valued using inputs observable in active markets and are therefore classified as Level 1 within the fair value hierarchy.

2. Property and Equipment (Tabl

2. Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2020
Table Text Block Supplement [Abstract]
Schedule of Property and Equipment	Property and equipment consisted of the following at March 31, 2020 and December 31, 2019: March 31, 2020 December 31, 2019 Furniture and Equipment $ 193,769 $ 17,414 Leasehold Improvements 2,500 2,500 196,269 19,914 Less: Accumulated Depreciation (13,791) (13,474) Net Property and Equipment $ 182,478 $ 6,440

3. Intangibles and Goodwill (Ta

3. Intangibles and Goodwill (Tables)	3 Months Ended
	Mar. 31, 2020
Table Text Block Supplement [Abstract]
Schedule of Intangible Assets	The Company considers all intangibles to be definite-lived assets with lives of 5 to 10 years. Intangibles consisted of the following at March 31, 2020 and December 31, 2019: March 31, 2020 December 31, 2019 CBDS.com website (Cannabis Sativa) $ 13,999 $ 13,999 Intellectual Property Rights (PrestoCorp) 240,000 240,000 Patents and Trademarks (KPAL) 1,281,411 1,281,411 Total Intangibles 1,535,410 1,535,410 Less: Accumulated Amortization (891,510) (840,192) Net Intangible Assets $ 643,900 $ 695,218
Amortization	Amortization of intangibles for each of the next five years is: 2021 $ 196,239 2022 $ 167,323 2023 $ 159,321 2024 $ 121,017

6. Stockholders' Equity (Tables

6. Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2020
Disclosure Text Block [Abstract]
Related and non-related parties	The following table breaks out the issuances by type of transaction and by related and non-related parties under the plan. Three months ended March 31, 2020 Acquistions Services Total Related Parties Common Value Common Preferred Value Common Preferred Value David Tobias, Officer, Director - $ - - 89,286 $ 42,857 - 89,286 $ 42,857 Brad Herr, Officer, Director - - 131,964 - 63,342 131,964 - 63,342 Robert Tankson, Director - - 84,326 - 40,476 84,326 - 40,476 Cathy Carroll, Director - - 89,286 - 42,857 89,286 - 42,857 Trevor Reed, Director - - 14,881 - 7,142 14,881 - 7,142 Total for related parties - $ - 320,457 89,286 $ 196,674 320,457 89,286 $ 196,674 Related parties - acquistion 100,000 $ 109,000 652,923 - $ 395,401 752,923 - $ 504,401 Aggregate Totals 100,000 $ 109,000 973,380 89,286 $ 592,075 1,073,380 89,286 $ 701,075 The following table breaks out the issuances by type of transaction and by related and non-related parties under the plan. Three months ended March 31, 2019 Services Common Preferred Value Unrelated parties issued 35,000 - $ 116,000 Unrelated Parties Cancelled (70,000) - - Aggregate Totals (35,000) - $ 116,000

7. Commitments and Contingenc_2

7. Commitments and Contingencies (Table)	3 Months Ended
	Mar. 31, 2020
Disclosure Text Block [Abstract]
Future minimum lease payments over the remaining term	Future minimum lease payments over the remaining term are as follows: Nine months ended December 31, 2020 $ 6,143 Twelve months ended December 31, 2021 8,190 Twelve months ended December 31, 2022 8,190 Six months ended June 30, 2023 4,095 Total 26,618 Less imputed interest (5,498) Net lease liability 21,120 Current portion (6,498) Long term $ 14,622

1. Organization and Summary o_3

1. Organization and Summary of Significant Accounting Policies: Nature of Business (Details)	Mar. 31, 2020	Aug. 01, 2017
PrestoCorp
Equity Method Investment, Ownership Percentage	51.00%	51.00%

1. Organization and Summary o_4

1. Organization and Summary of Significant Accounting Policies: Principles of Consolidation (Details)	Mar. 31, 2020	Aug. 01, 2017
PrestoCorp
Equity Method Investment, Ownership Percentage	51.00%	51.00%
GK Manufacturing Inc
Equity Method Investment, Ownership Percentage	51.00%

1. Organization and Summary o_5

1. Organization and Summary of Significant Accounting Policies: Going Concern (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Organization And Summary Of Significant Accounting Policies Going Concern
Accumulated deficit	$ (75,471,554)	$ (74,855,147)

1. Organization and Summary o_6

1. Organization and Summary of Significant Accounting Policies: Inventories (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Text Block [Abstract]
Inventories	$ 64,892	$ 0

1. Organization and Summary o_7

1. Organization and Summary of Significant Accounting Policies: Property and Equipment (Details)	3 Months Ended
	Mar. 31, 2020
Minimum
Property, Plant and Equipment, Useful Life	5 years
Maximum
Property, Plant and Equipment, Useful Life	10 years

1. Organization and Summary o_8

1. Organization and Summary of Significant Accounting Policies: Net Loss per Share (Details) - shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	125,000	49,900
Convertible Series A preferred stock
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,254,012	798,885

1. Organization and Summary o_9

1. Organization and Summary of Significant Accounting Policies: Intangible Assets (Details)	3 Months Ended
	Mar. 31, 2020
Minimum
Finite-Lived Intangible Asset, Useful Life	5 years
Maximum
Finite-Lived Intangible Asset, Useful Life	10 years

1. Organization and Summary _10

1. Organization and Summary of Significant Accounting Policies: Advertising Expense (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Text Block [Abstract]
Advertising Expense	$ 87,088	$ 33,153

2. Property and Equipment (Deta

2. Property and Equipment (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Disclosure Text Block [Abstract]
Depreciation expense	$ 317	$ 779

2. Property and Equipment Sched

2. Property and Equipment Schedule of Property and Equipment (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 196,269	$ 19,914
Less: accumulated depreciation	(13,791)	(13,474)
Property and Equipment, Net	182,478	6,440
Furniture and Equipment
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	193,769	17,414
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 2,500	$ 2,500

3. Intangibles and Goodwill (De

3. Intangibles and Goodwill (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Amortization of Intangible Assets	$ 51,318	$ 139,739
Impairment expense of intangible assets	1,039,926
PrestoCorp
Impairment of goodwill	3,010,202
Cumulative impairment of goodwill	1,173,000		$ 1,173,000
Ibudtender
Impairment of goodwill	336,667
Cumulative impairment of goodwill	$ 336,667		$ 336,667
Minimum
Finite-Lived Intangible Asset, Useful Life	5 years
Maximum
Finite-Lived Intangible Asset, Useful Life	10 years

3. Intangibles and Goodwill _ S

3. Intangibles and Goodwill : Schedule of Intangible Assets (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets, Gross	$ 1,535,410	$ 1,535,410
Less: Accumulated Amortization	(891,510)	(840,192)
Finite-Lived Intangible Assets, Net	643,900	695,218
Cannabis Sativa | Internet Domain Names
Finite-Lived Intangible Assets, Gross	13,999	13,999
PrestoCorp | Intellectual Property
Finite-Lived Intangible Assets, Gross	240,000	240,000
KPAL | Patents And Trademarks
Finite-Lived Intangible Assets, Gross	$ 1,281,411	$ 1,281,411

3. Intangibles and Goodwill _ A

3. Intangibles and Goodwill : Amortization (Details)	Mar. 31, 2020USD ($)
Disclosure Text Block [Abstract]
2021	$ 196,239
2022	167,323
2023	159,321
2024	$ 121,017

4. Related Party Transactions (

4. Related Party Transactions (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Net advances	$ 1,084,020		$ 1,018,520
Interest Expense	13,552	$ 10,843
Investor
Interest Expense	13,552	10,843
Accrued interest	100,767		87,979
Consultant
Other General and Administrative Expense	45,000	17,000
Officer
Compensation expense	$ 196,674	$ 0
Minimum
Debt Instrument, Interest Rate, Stated Percentage	5.00%
Maximum
Debt Instrument, Interest Rate, Stated Percentage	8.00%
Ibudtender Inc
Debt Instrument, Interest Rate, Stated Percentage	0.00%
Note Payable	$ 10,142		$ 10,142

5. Investments (Details)

5. Investments (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Investments, All Other Investments [Abstract]
Stock Issued During Period, Shares, Purchase of Assets	10,000,000
Stock Issued During Period, Value, Purchase of Assets	$ 200,000
Fair value of investment	67,000		$ 48,000
Unrealized loss on investment	$ 19,000	$ 0	$ 152,000

6. Stockholders' Equity (Detail

6. Stockholders' Equity (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2018
Common Stock, Par or Stated Value Per Share	$ 0.001		$ 0.001
Common Stock, Shares Authorized	45,000,000		45,000,000
Preferred Stock, Shares Authorized	5,000,000		5,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.001		$ 0.001
Conversion of stocks	In the three months ended March 31, 2020, a related party converted 80,337 preferred shares into 80,337 shares of common stock. No preferred shares were converted in the three months ended March 31, 2019
Salary	$ 184,909	$ 32,634
Stock issued for Acquisitions, Value	$ 213,725
Warrants outstanding	125,000		174,900
Number of shares converted	80,337
Stock Payable	$ 0		$ 640,685	$ 532,146
GKMP
Fair value	$ 109,000
Controlling interest	51.00%
President [Member] | GKMP
Controlling interest	49.00%
Officers And Directors
Issuance of stock, Value	$ 196,674	$ 340,198
GKMP
Assets value description	The assets were valued at $213,725, of which $104,725 relates to the 49% non-controlling interest. GKMP also assumed the payments on a lease for equipment, agreed to provide up to $500,000 of additional working capital to GKMP, and agreed to an earnout provision where additional shares of common stock may become issuable to the key individuals in the event certain performance standards are met
GKMP | President [Member]
Salary	$ 65,000
Stock issued for Acquistions, shares	50,000
Stock issued for Acquisitions, Value	$ 36,000
GKMP | Vice President [Member]
Salary	$ 50,000
Warrant
Warrants exercise price	$ 0.80
Warrants expire	125,000
Warrants expire date	Nov. 30, 2022
Warrant
Warrants exercise price	$ 2
Warrants expire	49,900
Warrants expire date	Feb. 1, 2020
Common Stock
Stock issued for Acquistions, shares	100,000
Stock issued for Acquisitions, Value	$ 100
Issuance of stock, Shares	963,238	127,061
Common Stock | Officers And Directors
Issuance of stock, Shares	39,391	85,681
Common Stock | 2017 Stock Plan
Common Stock issued to compensate employees and consultants		3,000,000
Additional shares authorized	954,720
Preferred Stock [Member]
Stock issued for Acquistions, shares
Stock issued for Acquisitions, Value
Issuance of stock, Shares	223,214	39,391
Preferred Stock [Member] | Officers And Directors
Issuance of stock, Shares	223,214	521,411
Preferred Stock [Member] | Common Class A
Preferred Stock, Shares Authorized	5,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.001
Preferred Stock, Voting Rights	1 vote per share

6. Stockholders' Equity (Relate

6. Stockholders' Equity (Related and non-related parties) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Stock issued for Acquisitions, Value	$ 213,725
Stock issued for services, Value	592,075	$ 116,000
David Tobias
Stock issued for Acquisitions, Value	0
Stock issued for services, Value	42,857
Total stock issued, value	42,857
Brad Herr
Stock issued for Acquisitions, Value	0
Stock issued for services, Value	63,342
Total stock issued, value	63,342
Robert Tankson
Stock issued for Acquisitions, Value	0
Stock issued for services, Value	40,476
Total stock issued, value	40,476
Cathy Carroll
Stock issued for Acquisitions, Value	0
Stock issued for services, Value	42,857
Total stock issued, value	42,857
Trevor Reed
Stock issued for Acquisitions, Value	0
Stock issued for services, Value	7,142
Total stock issued, value	7,142
Related Parties
Stock issued for Acquisitions, Value	0
Stock issued for services, Value	196,674
Total stock issued, value	196,674
Related parties - acquistion
Stock issued for Acquisitions, Value	109,000
Stock issued for services, Value	395,401
Total stock issued, value	504,401
Aggregate Totals
Stock issued for Acquisitions, Value	109,000
Stock issued for services, Value	592,075	116,000
Total stock issued, value	$ 701,075
Unrelated parties cancelled
Stock issued for services, Value		0
Unrelated parties issued
Stock issued for services, Value		$ 116,000
Common Stock
Stock issued for Acquistions, shares	100,000
Stock issued for Acquisitions, Value	$ 100
Stock issued for services, shares	973,380	35,000
Stock issued for services, Value	$ 973	$ 35
Common Stock | David Tobias
Stock issued for Acquistions, shares	0
Stock issued for services, shares	0
Total stock issued, shares	0
Common Stock | Brad Herr
Stock issued for Acquistions, shares	0
Stock issued for services, shares	131,964
Total stock issued, shares	131,964
Common Stock | Robert Tankson
Stock issued for Acquistions, shares	0
Stock issued for services, shares	84,326
Total stock issued, shares	84,326
Common Stock | Cathy Carroll
Stock issued for Acquistions, shares	0
Stock issued for services, shares	89,286
Total stock issued, shares	89,286
Common Stock | Trevor Reed
Stock issued for Acquistions, shares	0
Stock issued for services, shares	14,881
Total stock issued, shares	14,881
Common Stock | Related Parties
Stock issued for Acquistions, shares	0
Stock issued for services, shares	320,457
Total stock issued, shares	320,457
Common Stock | Related parties - acquistion
Stock issued for Acquistions, shares	100,000
Stock issued for services, shares	652,923
Total stock issued, shares	752,923
Common Stock | Aggregate Totals
Stock issued for Acquistions, shares	100,000
Stock issued for services, shares	973,380	(35,000)
Total stock issued, shares	1,073,380
Common Stock | Unrelated parties cancelled
Stock issued for services, shares		(70,000)
Common Stock | Unrelated parties issued
Stock issued for services, shares		35,000
Preferred Stock [Member]
Stock issued for Acquistions, shares
Stock issued for Acquisitions, Value
Stock issued for services, shares	89,286
Stock issued for services, Value	$ 89
Preferred Stock [Member] | David Tobias
Stock issued for services, shares	89,286
Total stock issued, shares	89,286
Preferred Stock [Member] | Brad Herr
Stock issued for services, shares	0
Total stock issued, shares	0
Preferred Stock [Member] | Robert Tankson
Stock issued for services, shares	0
Total stock issued, shares	0
Preferred Stock [Member] | Cathy Carroll
Stock issued for services, shares	0
Total stock issued, shares	0
Preferred Stock [Member] | Trevor Reed
Stock issued for services, shares	0
Total stock issued, shares	0
Preferred Stock [Member] | Related Parties
Stock issued for services, shares	89,286
Total stock issued, shares	89,286
Preferred Stock [Member] | Related parties - acquistion
Stock issued for services, shares	0
Total stock issued, shares	0
Preferred Stock [Member] | Aggregate Totals
Stock issued for services, shares	89,286	0
Total stock issued, shares	89,286
Preferred Stock [Member] | Unrelated parties cancelled
Stock issued for services, shares		0
Preferred Stock [Member] | Unrelated parties issued
Stock issued for services, shares		0

7. Commitments and Contingenc_3

7. Commitments and Contingencies (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Aug. 01, 2017
Operating lease liability	$ 21,120
Right of use asset	$ 21,120		$ 0
Shares in Escrow	Company has 419,475 shares of common stock in escrow as part of the acquisition of PrestoCorp. These shares are issuable in certain circumstances to the principals of PrestoCorp based on performance of the PrestoCorp business in 2020 and 2021. The escrow account originally contained 629,213 shares of common stock but 209,738 shares were cancelled in 2018 when the performance requirements were not met. The escrowed shares are not counted in the outstanding stock of the Company and will be considered compensation to the principals if and when issued. The escrow account also includes an additional 500 shares of PrestoCorp common stock which is distributable either back to the principals of PrestoCorp or to the Company, also depending on certain minimum performance requirements which extend into 2021.
PrestoCorp
Operating Leases, Rent Expense	$ 7,322	$ 8,044
Equity Method Investment, Ownership Percentage	51.00%			51.00%
Warehouse Lease
Debt Instrument, Periodic Payment	$ 600
San Francisco Office Facilities | PrestoCorp
Debt Instrument, Periodic Payment	2,800
New York office Facilities | PrestoCorp
Debt Instrument, Periodic Payment	2,444
Las Vegas Office Facilities | PrestoCorp
Debt Instrument, Periodic Payment	1,500
GKMP
Operating Leases, Rent Expense	683
Operating lease liability	23,286
Right of use asset	$ 23,286
Discount Rate	10.00%
Lease term	39 months
Deposit	$ 1,250
Net revenues description	If GKMP net revenues exceed $3,000,000 and net income exceeds 25% of net revenues in the year ended December 31, 2020, an additional $1,000,000 in consideration will be due to the key individuals. If GKMP net revenues exceed $6,000,000 and net income exceeds 25% of net revenues in the year ended December 31, 2020, an additional $500,000 in consideration will be due to the key individuals ($1,500,000 in the aggregate).
Additional working capital	$ 500,000
Working capital payments	49.00%

7. Commitments and Contingenc_4

7. Commitments and Contingencies: Stock Payable (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Disclosure Text Block [Abstract]
Nine months ended December 31, 2020	$ 6,143
Twelve months ended December 31, 2021	8,190
Twelve months ended December 31, 2022	8,190
Six months ended June 30, 2023	4,095
Total	26,618
Less: imputed interest	(5,498)
Net lease liability	21,120
Current portion	(6,498)	$ 0
Long term	$ 14,622	$ 0